14h
One Rare Disease Biotech Posts 97% Margins but the Faster Growing Rival Just Turned Its First Profit
Corcept Therapeutics (NASDAQ: CORT) and Amicus Therapeutics (NASDAQ: FOLD) delivered Q3 2025 results highlighting two rare ...
The movement of waves, patterns that carry sound, light or heat, through materials has been widely studied by physicists, as ...
Dopamine plays a more complex and precise role in brain function than previously thought: it not only enhances neural ...
COHERENT’S NEW COMPACT 1W VISIBLE LASER PLATFORM SETS A NEW STANDARD FOR LIFE SCIENCE AND SEMICONDUCTOR INNOVATIONS Coherent ...
January 2026 Consumer Search Analysis Examines How Shoppers Evaluate Single-Ingredient vs Multi-Ingredient Berberine ...
The FDA has approved ProlivRx, the first prescription, home-based brain neuromodulation therapy, as an adjunctive treatment ...
The trailblazing soft synth that we’d all but given up hope on has made a glorious comeback, but how does Absynth fit into a ...
Moderna now anticipates ending 2025 with cash and cash equivalents worth $8.1 billion, up from its previous forecast of ...
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and begins in the cells lining the ...
Each input channel provides mic, line and Hi-Z connectivity with phantom power available. Input levels are controlled by a ...
3. Wash inside out: Turning the uniform inside out will prevent its colours from bleeding, which will lead to premature ...
A Japanese research team has launched a trial of "anime therapy," a method in which animated characters provide counseling to young people facing social challenges. The initiative marks Japan's first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback